Viewing Study NCT05928468


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2025-12-25 @ 3:58 PM
Study NCT ID: NCT05928468
Status: UNKNOWN
Last Update Posted: 2023-07-03
First Post: 2023-06-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002
Sponsor: Guangzhou Patronus Biotech Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module